Analyst Reco. Fulgent Genetics, Inc.

Equities

FLGT

US3596641098

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
21.14 ^USD	-0.98%		-6.04%	-26.88%

May. 03	Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024
May. 03	Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piper Sandler Adjusts Price Target on Fulgent Genetics to $25 From $28, Maintains Neutral Rating	Mar. 06	MT
UBS Adjusts Fulgent Genetics Price Target to $25 From $35, Maintains Neutral Rating	Feb. 29	MT
UBS Initiates Coverage on Fulgent Genetics With Neutral Rating, $35 Price Target	Dec. 07	MT
Fulgent Genetics Swings to Loss in Q2, Revenue Declines; Raises Guidance; Shares Surge 10% Pre-Bell	23-08-04	MT
Credit Suisse Lowers Fulgent Genetics' Price Target to $45 From $50 After Mixed Q4 Results, Keeps Outperform Rating	23-03-02	MT
Piper Sandler Downgrades Fulgent Genetics to Neutral From Overweight, Adjusts Price Target to $40 From $65	22-12-08	MT
Raymond James Starts Fulgent Genetics at Outperform With $45 Price Target	22-11-18	MT
Piper Sandler Adjusts Price Target on Fulgent Genetics to $65 From $70, Maintains Overweight Rating	22-11-14	MT
Credit Suisse Adjusts Fulgent Genetics' Price Target to $50 From $65, Keeps Outperform Rating	22-11-14	MT
Credit Suisse Initiates Fulgent Genetics at Outperform with $65 Price Target	22-08-25	MT
Piper Sandler Adjusts Fulgent Genetics' Price Target to $70 From $85, Reiterates Overweight Rating	22-05-16	MT
Oppenheimer Adjusts Fulgent Genetics Price Target to $112 From $123, Maintains Outperform Rating	22-05-04	MT
Piper Sandler Adjusts Fulgent Genetics' Price Target to $85 From $80, Reiterates Overweight Rating	22-03-01	MT
Oppenheimer Adjusts Fulgent Genetics Price Target to $123 From $125, Maintains Outperform Rating	22-02-24	MT
Piper Sandler Assumes Fulgent Genetics at Overweight with $80 Price Target	22-02-04	MT
Oppenheimer Adjusts Fulgent Genetics' Price Target to $125 From $141, Maintains Outperform Rating	22-01-25	MT
FULGENT GENETICS : Credit Suisse Adjusts Fulgent Genetics' Price Target to $65 from $55, Keeps Underperform Rating	21-08-10	MT
FULGENT GENETICS : Oppenheimer Adjusts Fulgent Genetics PT to $141 From $118, Maintains Outperform Rating	21-08-10	MT
FULGENT GENETICS : Oppenheimer Adjusts Fulgent Genetics PT to $118 From $126, Maintains Outperform Rating	21-05-07	MT
FULGENT GENETICS : Oppenheimer Adjusts Fulgent Genetics PT to $126 From $130 on Q1 Preview, Maintains Outperform Rating	21-04-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Fulgent Genetics, Inc.

Equities

FLGT

US3596641098

Analyst Reco.

Filters